Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau
Annals of Neurology · 2024-05 · 95 (5) · 917-928
DOI: 10.1002/ana.26885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 14.02.2024. Verfasst von Guoyu Lan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Bay Laboratory, Institute of Biomedical Engineering, Shenzhen, China. Hauptthemen laut MEDLINE: Microglia, Amyloid beta-Peptides, tau Proteins, Alzheimer Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Objective
Triggering receptor expressed on myeloid cells‐2 (TREM2) and progranulin (PGRN) are critical regulators of microglia activation and can be detected in cerebrospinal fluid (CSF). However, whether microglial reactivity is detrimental or neuroprotective for Alzheimer disease (AD) is still debatable.
Methods
We identified 663 participants with baseline β‐amyloid (Aβ) positron emission tomography (PET) and CSF biomarker data, including phosphorylated tau181 (p‐Tau 181 ), soluble TREM2 (sTREM2), PGRN, and growth‐associated protein‐43 (GAP‐43). Among them, 254 participants had concurrent longitudinal CSF biomarkers. We used multivariate regression analysis to study the associations of CSF microglial biomarkers with Aβ PET, CSF p‐Tau 181 , and CSF GAP‐43 cross‐sectionally and longitudinally. A Chinese aging cohort's independent CSF samples (n = 65) were analyzed as a validation.
Results
Higher baseline levels of CSF microglial biomarkers were related to faster rates of CSF sTREM2 increase and CSF PGRN decrease. Elevated CSF p‐Tau 181 was associated with higher levels of CSF microglial biomarkers and faster rates of CSF sTREM2 increase and CSF PGRN decrease. In both cohorts, higher Aβ burden was associated with attenuated CSF p‐Tau 181 effects on CSF microglial biomarker increases. Independent of Aβ PET and CSF p‐Tau 181 pathologies, higher levels of CSF sTREM2 but not CSF PGRN were related to elevated CSF GAP‐43 levels and faster rates of CSF GAP‐43 increase.
Interpretation
These findings suggest that higher Aβ burden may attenuate the p‐Tau‐associated microglial responses, and TREM2‐related microglial reactivity may independently correlate with GAP‐43‐related presynaptic loss. This study highlights the two‐edged role of microglial reactivity in AD and other neurodegenerative diseases. ANN NEUROL 2024;95:917–928
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Bay Laboratory, Institute of Biomedical Engineering, Shenzhen, China.
- Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
- Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China.
- Peking University Shenzhen Graduate School, Shenzhen, China.
ORCID-Profile: Tengfei Guo
Förderung
- NIA NIH HHS
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Lan, G., Chen, X., Yang, J., Sun, P., Cai, Y., Li, A., Zhu, Y., Liu, Z., Ma, S., Guo, T., & Alzheimer's Disease Neuroimaging Initiative (2024). Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau. Annals of Neurology, 95(5), 917-928. https://doi.org/10.1002/ana.26885
Vancouver
Lan G, Chen X, Yang J, Sun P, Cai Y, Li A, et al. Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau. Annals of Neurology. 2024;95(5):917-928. doi:10.1002/ana.26885
BibTeX
@article{Lan2024,
author = {Lan, Guoyu and Chen, Xuhui and Yang, Jie and Sun, Pan and Cai, Yue and Li, Anqi and Zhu, Yalin and Liu, Zhen and Ma, Shaohua and Guo, Tengfei and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau},
journal = {Annals of Neurology},
year = {2024},
volume = {95},
number = {5},
pages = {917--928},
doi = {10.1002/ana.26885}
}
EUVIMED